Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor
about
In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl proteaseIn vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor.Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir.Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitorsSecond locus involved in human immunodeficiency virus type 1 resistance to protease inhibitorsAntiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitorThe antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rateCharacterization of siamycin I, a human immunodeficiency virus fusion inhibitorAntiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus proteaseGenetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitorImpaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitorsGenotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapyDeoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rateIdentification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisEmergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detectionIn vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects.Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAVEvaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.Protease inhibitors as antiviral agents.Constrained evolution of human immunodeficiency virus type 1 protease during sequential therapy with two distinct protease inhibitorsReplicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo.Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients.Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug.
P2860
Q28344594-699957C9-D564-4B7F-A9BC-287605761348Q28367941-630A7B50-B2BC-4C7D-BBD3-845D42819245Q28368369-04B775BB-2456-4121-B9CD-A8B83E24989AQ28369030-5884DC52-1327-4B42-B547-6454BC2B93B5Q28378853-33BBA832-B18C-4903-A805-DB6EF408F022Q28378860-9D9965FB-FC96-411C-848F-F8CA6923B14EQ28378892-4E9E83B5-123D-46B1-B7A5-3ED17C52685AQ28378929-AD082FE7-5734-4900-B613-1202D072527CQ28379084-6658D4A0-F4F8-47D9-B447-E58DA76FEF34Q28379166-BA62E06D-E4F9-4ED6-AE00-2BE2101DFC84Q28379356-3AF2EF3A-E900-40C9-AAE8-C66609603E6EQ28379411-1DEC9B97-9FD6-45FD-BB53-E4F0367C5DD1Q33784635-97595A5A-F129-4190-84DF-6C3B4C7C057CQ33784748-3B351ADF-1818-4903-9E04-B77628313276Q33804495-C89FC15A-7FDD-4D2F-AC5B-832BAD8AED19Q33846032-171FE2CF-B51B-4D87-9ED6-68B7DB1898FAQ33962513-6043D8B7-8D3B-4479-BDCE-7B5FD6182332Q34010283-A052ED17-03DD-4D29-A0B5-0D18BEDFC852Q35129066-4E57F866-8CE0-44FD-860D-AAAEFC422337Q35857907-28314BE9-CAA0-466B-9B0A-0E1405577854Q36280729-A8021898-70D0-40F9-BAE2-F86D7F5AE016Q37544670-E643B705-317E-4E43-874A-EAF4F441D636Q39468942-365C30C9-0EED-476D-B2EE-078C2FE85F2CQ39549108-27658DD9-92D6-4BCA-AA9E-1F67509CE52AQ39550343-39BD775A-128C-4037-8F70-D088CA6DF1FEQ39579408-12A4CB9D-1E03-447F-B0EA-C4A413E45BF8Q39580564-CC9B120E-0A90-4F0E-B00E-643DD8EA04F0Q39612306-C6683BED-3397-4400-8FB1-5639E2603981
P2860
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Characterization of a human im ...... n aminodiol protease inhibitor
@ast
Characterization of a human im ...... n aminodiol protease inhibitor
@en
Characterization of a human im ...... n aminodiol protease inhibitor
@nl
type
label
Characterization of a human im ...... n aminodiol protease inhibitor
@ast
Characterization of a human im ...... n aminodiol protease inhibitor
@en
Characterization of a human im ...... n aminodiol protease inhibitor
@nl
prefLabel
Characterization of a human im ...... n aminodiol protease inhibitor
@ast
Characterization of a human im ...... n aminodiol protease inhibitor
@en
Characterization of a human im ...... n aminodiol protease inhibitor
@nl
P2093
P2860
P1433
P1476
Characterization of a human im ...... n aminodiol protease inhibitor
@en
P2093
A K Patick
C M Bechtold
J C Barrish
M A Hermsmeier
R J Colonno
P2860
P304
P407
P577
1995-04-01T00:00:00Z